^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Orathecin (rubitecan)

    Associations

    News
    Trials
    Company:
    Vivacitas
    Drug class:
    DNA topoisomerase inhibitor
    Related drugs:

    Associations

    News
    Trials